Navigation Links
Lionbridge Receives ISO 13485:2003 Certification for Quality Management
Date:3/10/2009

Certification Underscores Lionbridge's Market-Leading Translation Management Program for Life Sciences Organizations Worldwide

WALTHAM, Mass., March 10 /PRNewswire-FirstCall/ -- Lionbridge (Nasdaq: LIOX) today announced that it recently received ISO 13485:2003 certification which verifies quality management systems for medical device companies. This certification expands Lionbridge's dedicated Life Sciences program and enhances the Company's translation management platform to adhere to the rigorous compliance requirements of its medical device clients. Lionbridge was awarded this certification as part of its Life Sciences Center of Excellence initiative, which provides specialized translation services to leading medical device companies, pharmaceutical companies, and contract research organizations around the world.

"This independent certification reflects our proven level of excellence in delivering translation services for medical device and life sciences organizations. As the market leader in translation, Lionbridge is committed to providing the highest levels of quality and service to ensure our clients meet and exceed their customers' expectations while adhering to strict regulatory compliance regulations," said Henri Broekmate, General Manager, Global Language and Content, Lionbridge. "Our clients can take advantage of our superior capabilities in translation and other services with the confidence of knowing our processes comply with the demanding requirements of ISO 13485."

ISO 13485:2003 is an internationally recognized quality standard that outlines particular quality management system requirements tailored to the manufacture of medical devices. ISO 13485:2003 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer requirements and regulatory requirements applicable to medical devices and related services. The primary objective of ISO 13485:2003 is to facilitate harmonized medical device regulatory requirements for quality management systems. All requirements of ISO 13485:2003 are specific to organizations providing medical devices, regardless of the type or size of the organization.

Lionbridge's recent ISO 13485:2003 certification complements its existing ISO 9001-2000 certification.

About Lionbridge

Lionbridge Technologies, Inc. (Nasdaq: LIOX) is a leading provider of translation, development and testing services with FY 2008 revenue of $461 million. Lionbridge combines global resources with proven program management methodologies to serve as an outsource partner throughout a client's product and content lifecycle -- from development to translation, testing and maintenance. Global organizations rely on Lionbridge services to increase international market share, speed adoption of global products and content, and enhance their return on enterprise applications and IT system investments. Based in Waltham, Mass., Lionbridge maintains solution centers in 26 countries and provides services under the Lionbridge(R) and VeriTest(R) brands. To learn more, visit http://www.lionbridge.com.

    Contact: Sara Buda
             781-434-6190
             sara.buda@lionbridge.com


'/>"/>
SOURCE Lionbridge Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
2. IDM Pharmas MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma
3. Huntington Hospital Cancer Center Receives Outstanding Achievement Designation
4. Takeda Receives New Information on Alogliptin (SYR-322) NDA
5. AED Receives Gates Foundation Grant to Improve Nutrition and Reduce Deaths Among Young Children in Developing Countries
6. MedX Health Receives CE Mark for Laser & Light Products
7. SpectraScience Receives FDA Clearance for Manufacturing Facility
8. ProteoTech Receives Funding From The Michael J. Fox Foundation for Parkinsons Disease Research to Develop Tools for Imaging Alpha-Synuclein Aggregation in Living Parkinsons Brain
9. Medical University of South Carolina Hollings Cancer Center Receives National Cancer Institute Designation
10. SynCare Receives Managed Health Services Contract Renewal
11. UIC receives $3 million to study prostate cancer risk factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
Breaking Medicine Technology: